Heritage Oak Wealth Advisors LLC Reduces Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Heritage Oak Wealth Advisors LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 34.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 533 shares of the healthcare conglomerate’s stock after selling 275 shares during the quarter. Heritage Oak Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $279,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group in the 4th quarter worth about $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $307.69 on Thursday. The firm has a market capitalization of $279.12 billion, a PE ratio of 12.88, a price-to-earnings-growth ratio of 1.55 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The company’s fifty day moving average price is $329.50 and its 200-day moving average price is $450.21. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the prior year, the company earned $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.87%. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is currently 37.02%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Royal Bank Of Canada dropped their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. Wells Fargo & Company reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Truist Financial reissued a “buy” rating and issued a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, Wolfe Research cut their price target on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $415.57.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director owned 6,033 shares of the company’s stock, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of the firm’s stock in a transaction on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock valued at $31,607,768 in the last ninety days. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.